PIERIS PHARMACEUTICALS INC - COM (PIRS)

CUSIP: 720795103

Q1 2024 13F Holders as of 31 Mar 2024

Share change
-762,500
SEC-reported price per share
$0.18
Number of holders
37
Value change
-$138,911
Number of buys
13
Number of sells
12

Security key

720795103

Report period

Q1 2024

Institutions

37

Top holders

10

Ownership snapshot

Top reported holders of PIRS - PIERIS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $3,750,995 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $3.75M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.
Disclosed position value Top 5
BVF INC/IL $3.75M
Lynx1 Capital Management LP $1.78M
1620 INVESTMENT ADVISORS, INC. $317.6K
CITADEL ADVISORS LLC $216.6K
RENAISSANCE TECHNOLOGIES LLC $194K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
—
denominator unverified
$3,750,995
20,609,863 shares
— 31 Dec 2023
Lynx1 Capital Management LP
13F
Company
13F
—
denominator unverified
$1,779,205
9,775,849 shares
— 31 Dec 2023
1620 INVESTMENT ADVISORS, INC.
13F
Company
13F
—
denominator unverified
$317,605
4,421 shares
— 31 Dec 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$216,559
1,189,887 shares
— 31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$194,000
1,065,007 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$188,870
1,037,747 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
37
Shares
37,707,385
Rows available
37
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
37
Q1 2024 holders
37
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .